Das Bild zeigt eine Ärztin am Schreibtisch, die einem Patienten ein Röntgenbild erklärt.

Veröffentlichungen

Sie befinden sich hier:

Anbei finden Sie einige unserer Veröffentlichungen aus unserem Zentrum

Publikationen

AG Gastro-ösophageale Tumore Stand 07.07.2017

Originalarbeiten

Thuss-Patience PC, Shah MA, Ohtsu A, Van Cutsem E, Ajani JA, Castro H, Mansoor W, Chung HC, Gyorgy Bodoky G, Kohei Shitara K, Phillips GDL, van der Horst T, Harle-Yge ML, Althaus BL, KangYK: Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study THE LANCET ONCOLOGY, 2017, Epub ahead of print, Published online March, 2017 http://dx.doi.org/10.1016/S1470-2045(17)30111-0

Janowitz T, Thuss-Patience P, Marshall A, Kang JH, Connell C, Cook N, Dunn J, Park SH, Ford H. Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma: a meta-analysis of patient-level data. Br J Cancer. 2016 Feb 16;114(4):381-7. doi: 10.1038/bjc.2015.452. Both authors contributed equally as 1st authors

Moehler M, Gepfner-Tuma I, Maderer A, Thuss-Patience PC, Ruessel J, Hegewisch-Becker S, Wilke H, Al-Batran SE, Rafiyan MR, Weißinger F, Schmoll HJ, Kullmann F, von Weikersthal LF, Siveke JT, Weusmann J, Kanzler S, Schimanski CC, Otte M, Schollenberger L, Koenig J, Galle PR. Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program. BMC Cancer. 2016 Aug 31;16:699. doi: 10.1186/s12885-016-2736-9.

Berendt J, Oechsle K, Thomas M, van Oorschot B, Schmitz A, Radbruch L, Simon ST, Gärtner J, Thuß-Patience P, Schuler US, Hense J, Gog C, Viehrig M, Mayer-Steinacker R, Stachura P, Stiel S, Ostgathe C. [State of integration of palliative care at Comprehensive Cancer Centers funded by German Cancer Aid]. Dtsch Med Wochenschr. 2016 Jan;141(2):e16-23. doi: 10.1055/s-0041-106089. Epub 2016 Jan 22. German.

Andreou A, Biebl M, Dadras M, Struecker B, Sauer IM, Thuss-Patience PC, Chopra S, Fikatas P, Bahra M, Seehofer D, Pratschke J, Schmidt SC. Anastomotic leak predicts diminished long-term survival after resection for gastric and esophageal cancer. Surgery. 2016 Apr 8. pii: S0039-6060(16)00094-5. doi: 10.1016/j.surg.2016.02.020. [Epub ahead of print]

Porschen R, Buck A, Fischbach W, Gockel I, Görling U, Grenacher L, Hollerbach S, Hölscher A, Körber J, Messmann H, Meyer HJ, Miehlke S, Möhler M, Nöthlings U, Pech U, Schmidberger H, Schmidt M, Stahl M, Stuschke M, Thuss-Patience P, Trojan J, Vanhoefer U, Weimann A, Wenz F, Wullstein C. S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus (Langversion 1.0 - September 2015, AWMF-Registernummer: 021/023OL). Z Gastroenterol. 2015 Nov;53(11):1288-347. doi: 10.1055/s-0041-107381. Epub 2015 Nov 12. German. No abstract available.

van den Berg H, Paulussen M, Le Teuff G, Judson I, Gelderblom H, Dirksen U, Brennan B, Whelan J, Ladenstein RL, Marec-Berard P, Kruseova J, Hjorth L, Kühne T, Brichard B, Wheatley K, Craft A, Juergens H, Gaspar N, Le Deley MC; Euro-EWING99 Group. Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial. Eur J Cancer. 2015 Nov;51(16):2453-64. doi: 10.1016/j.ejca.2015.06.123. Epub 2015 Aug 10.

Bichev D, Treese C, von Winterfeld M, Breithaupt K, Dogan Y, Schmidt SC, Daum S, Thuss-Patience PC. High Impact of Histopathological Remission for Prognosis after Perioperative Chemotherapy with ECF and ECF-Like Regimens for Gastric and Gastroesophageal Adenocarcinoma. Oncology. 2015;89(2):95-102. doi: 10.1159/000376550. Epub 2015 Mar 21.

Lorenzen S, Riera Knorrenschild J, Haag GM, Pohl M, Thuss-Patience P, Bassermann F, Helbig U, Weißinger F, Schnoy E, Becker K, Stocker G, Rüschoff J, Eisenmenger A, Karapanagiotou-Schenkel I, Lordick F.Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.Eur J Cancer. 2015 Mar;51(5):569-76. doi: 0.1016/j.ejca.2015.01.059. Epub 2015 Feb 16.

Sylvie Lorenzen, Silvia Spörl, Salah-Eddin Al-Batran, Markus F, Florian Lordick, Peter Thuss-Patience, Bernhard H, Martin A, Alexander N. Impact of age on the feasibility and efficacy of neoadjuvant chemotherapy in patients with locally advanced oesophagogastric cancer.Eur J Cancer. 2015 Sep;51(14):1918-26. doi: 10.1016/j.ejca.2015.07.002.

Sturm I, Baak J, Storek B, Traore A, Thuss-Patience P. Effect of dance on cancer-related fatigue and quality of life. Support Care Cancer. 2014 Aug;22(8):2241-9. doi: 10.1007/s00520-014-2181-8. Epub 2014 Mar 27.

Kuehnle MC, Attig S, Britten CM, Schulze-Bergkamen H, Lordick F, von Wichert G, Thuss-Patience P, Stein A, Schuler M, Bassermann F, Sahin U, Türeci O.Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction.Cancer Immunol Immunother. 2014 Dec;63(12):1273-84. doi: 10.1007/s00262-014-1596-x. Epub 2014 Aug 28.

Andreou A, Viganò L, Zimmitti G, Seehofer D, Dreyer M, Pascher A, Bahra M, Schoening W, Schmitz V, Thuss-Patience PC, Denecke T, Puhl G, Vauthey JN, Neuhaus P, Capussotti L, Pratschke J, Schmidt SC. Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancer. J Gastrointest Surg. 2014 Nov;18(11):1974-86. doi: 10.1007/s11605-014-2623-0. Epub 2014 Aug 27.

Lorenzen S*, Thuss-Patience P*, Al-Batran SE, Lordick F, Haller B, Schuster T, Pauligk C, Luley K, Bichev D, Schumacher G, Homann N. Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy. Annals of Oncology 2013 Apr 16. [Epub ahead of print] * Both authors contributed equally as first author

Paoletti X, Oba K, Bang YJ, Bleiberg H, Boku N, Bouché O, Catalano P, Fuse N, Michiels S, Moehler M, Morita S, Ohashi Y, Ohtsu A, Roth A, Rougier P, Sakamoto J, Sargent D, Sasako M, Shitara K, Thuss-Patience P, Van Cutsem E, Burzykowski T, Buyse M; GASTRIC group.Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis. J Natl Cancer Inst. 2013 Nov 6;105(21):1667-70. doi: 10.1093/jnci/djt269. Epub 2013 Oct 9.

Stein A, Arnold D, Thuss-Patience PC, Moehler M, Grothe W, Seufferlein T, Reinacher-Schick A, Geissler M, Hofheinz RD, Schmoll HJ. Docetaxel, oxaliplatin and capecitabine (TEX regimen) in patients with metastatic gastric or gastro-esophageal cancer: results of a multicenter phase I/II study. Acta Oncol. 2014 Mar;53(3):392-8. doi: 10.3109/0284186X.2013.833346. Epub 2013 Sep 12.

GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group, Oba K, Paoletti X, Bang YJ, Bleiberg H, Burzykowski T, Fuse N, Michiels S, Morita S, Ohashi Y, Pignon JP, Rougier P, Sakamoto J, Sargent D, Sasako M, Shitara K, Tsuburaya A, Van Cutsem E, Buyse M. Collaborators: Buyse M, Michiels S, Oba K, Paoletti X, Rougier P, Yamamoto S, Nakamura K, Bang YJ, Bleiberg H, Burzykowski T, Buyse M, Delbaldo C, Michiels S, Morita S, Oba K, Ohashi Y, Paoletti X, Pignon JP, Rougier P, Sakamoto J, Sargent D, Sasako M, Van Cutsem E, Ajani J, Boku N, Barone C, Borner M, Bouche O, Bugat R, Coombes C, Cullinan S, Dank M, Douglass H, Fuse N, Glimelius B, Hawkins R, Kanzler S, Koizumi W, Kim TW, Lordick F, Moehler M, Nio Y, Ohtsu A, Pozzo C, Reichardt P, Roth A, Schumacher C, Shitara K, Thuss-Patience P, Tsuburaya A, Van Cutsem E, Vanhoefer U, Wils J, Yamamura Y. Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis. European Journal of Cancer. 2013 May;49(7):1565-77. doi: 10.1016/j.ejca.2012.12.016. Epub 2013 Jan 24.

Thuss-Patience PC, Hofheinz RD, Arnold D, Florschütz A, Daum S, Kretzschmar A, Mantovani-Löffler L, Bichev D, Breithaupt K, Kneba M, Schumacher G, Glanemann M, Schlattmann P, Reichardt P, Gahn B. Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma - a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO), Annals of Oncology. 2012 Jun 24. [Epub ahead of print]

Geisel D, Denecke T, Collettini F, Grieser C, Wust P, Thuss-Patience P, Hamm B, Gebauer B. Treatment of hepatic metastases from gastric or gastroesophageal adenocarcinoma with computed tomography-guided high-dose-rate brachytherapy (CT-HDRBT).Anticancer Research. 2012 Dec;32(12):5453-8.

Thuss-Patience P, Kretzschmar A, Dogan Y, Rothmann F, Blau I, Schwaner I, Breithaupt K, Bichev D, Grothoff M, Grieser C, Reichardt P.Docetaxel and Capecitabine for Advanced Gastric Cancer: Investigating Dose-Dependent Efficacy in Two Patient Cohorts, British Journal of Cancer. 2011 Aug 9;105(4):505-12

Thuss-Patience P, Kretzschmar A, Bichev D, Deist T, Hinke A, Breithaupt K, Dogan Y, Gebauer B, Schumacher G, Reichardt P. Survival advantage for irinotecan versus best supportive care as 2nd-line chemotherapy in gastric cancer - a randomized phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). European Journal of Cancer. 2011 Oct;47(15):2306-14

Flörcken A, Schaefer C, Bichev D, Breithaupt K, Dogan Y, Schumacher G, Gebauer B, Riess H, Dörken B, Thuss-Patience P. Hepatic arterial infusion chemotherapy for liver metastases from gastric cancer: an analysis in Western patients. Tumori, 97: 19-24, 2011

Moehler M, Al-Batran SE, Andus T, Anthuber M, Arends J, Arnold D, Aust D, Baier P, Baretton G, Bernhardt J, Boeing H, Böhle E, Bokemeyer C, Bornschein J, Budach W, Burmester E, Caca K, Diemer WA, Dietrich CF, Ebert M, Eickhoff A, Ell C, Fahlke J, Feussner H, Fietkau R, Fischbach W, Fleig W, Flentje M, Gabbert HE, Galle PR, Geissler M, Gockel I, Graeven U, Grenacher L, Gross S, Hartmann JT, Heike M, Heinemann V, Herbst B, Herrmann T, Höcht S, Hofheinz RD, Höfler H, Höhler T, Hölscher AH, Horneber M, Hübner J, Izbicki JR, Jakobs R, Jenssen C, Kanzler S, Keller M, Kiesslich R, Klautke G, Körber J, Krause BJ, Kuhn C, Kullmann F, Lang H, Link H, Lordick F, Ludwig K, Lutz M, Mahlberg R, Malfertheiner P, Merkel S, Messmann H, Meyer HJ, Mönig S, Piso P, Pistorius S, Porschen R, Rabenstein T, Reichardt P, Ridwelski K, Röcken C, Roetzer I, Rohr P, Schepp W, Schlag PM, Schmid RM, Schmidberger H, Schmiegel WH, Schmoll HJ, Schuch G, Schuhmacher C, Schütte K, Schwenk W, Selgrad M, Sendler A, Seraphin J, Seufferlein T, Stahl M, Stein H, Stoll C, Stuschke M, Tannapfel A, Tholen R, Thuss-Patience P, Treml K, Vanhoefer U, Vieth M, Vogelsang H, Wagner D, Wedding U, Weimann A, Wilke H, Wittekind C; AWMF; AWMF. [German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Zeitschrift für Gastroenterologie. 2011 Apr;49(4):461-531. doi: 10.1055/s-0031-1273201. Epub 2011 Apr 7.

Schumacher G, Schlechtweg N, Chopra SS, Rösch T, Veltzke-Schlieker W, Thuss-Patience P, Schmidt SC, Neuhaus P. [Impact of the body mass index on the prognosis and complication rate after surgical resection of cancers at the oesophagogastric junction]. Zentralblatt für Chirurgie. 2009 Feb;134(1):66-70. Epub 2009 Feb 25.

Schumacher G, Schmidt SC, Schlechtweg N, Roesch T, Sacchi M, von Dossow V, Chopra SS, Pratschke J, Zhukova J, Stieler J, Thuss-Patience P, Neuhaus P. Surgical results of patients after esophageal resection or extended gastrectomy for cancer of the esophagogastric junction. Diseases of the Esophagus. 2009 Jan 23. [Epub ahead of print]

Presser SJ, Schumacher G, Neuhaus R, Thuss-Patience P, Stieler J, Neuhaus P. De novo esophageal neoplasia after liver transplantation. Liver Transplantation. 2007 Mar;13(3):443-50.

Pink D, Lindner T, Mrozek A, Kretzschmar A, Thuss-Patience PC, Dörken B, Reichardt P. Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature. Gynecologic Oncology. 2006 Jun;101(3):464-9. Epub 2005 Dec 20.

Thuss-Patience PC, Kretzschmar A, Repp M, Kingreen D, Hennesser D, Micheel S, Pink D, Scholz C, Dorken B, Reichardt P. Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II study. Journal of Clinical Oncology. 2005 Jan 20;23(3):494-501.

Thuss-Patience PC, von Minckwitz G, Kretzschmar A, Loibl S, Schaller G, Dörken B, Reichardt P. Oxaliplatin and 5-fluorouracil for heavily pretreated metastatic breast cancer: a preliminary phase II study. Anticancer Drugs. 2003 Aug;14(7):549-53.

Trappe R, Loew A, Thuss-Patience P, Dorken B, Riess H. Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab-monitoring of antiphospholipid and anti-GP antibodies: a case report. Annals of Hematology. 2005 Nov 15;:1-2

Köhne CH, Catane R, Klein B, Ducreux M, Thuss-Patience P, Niederle N, Gips M, Preusser P, Knuth A, Clemens M, Bugat R, Figer I, Shani A, Fages B, Di Betta D, Jacques C, Wilke HJ. Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial. British Journal of Cancer. 2003 Sep 15;89(6):997-1001.

Reichardt P, Von Minckwitz G, Thuss-Patience PC, Jonat W, Kolbl H, Janicke F, Kieback DG, Kuhn W, Schindler AE, Mohrmann S, Kaufmann M, Luck HJ. Multicenter phase II study of oral capecitabine (Xeloda) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy. Annals of Oncology. 2003 Aug;14(8):1227-33. Reichardt P, Lindner T, Pink D, Thuss-Patience PC, Kretzschmar A, Dörken B. Chemotherapy in alveolar soft part sarcomas. What do we know? European Journal of Cancer. 2003 Jul;39(11):1511-6.

Reichardt P, Pink D, Tilgner J, Kretzschmar A, Thuss-Patience PC, Dörken B. Oral trofosfamide: an active and well-tolerated maintenance therapy for adult patients with advanced bone and soft tissue sarcomas. Results of a retrospective analysis. Onkologie. 2002 Dec;25(6):541-6.

Kretzschmar A, Reichardt P, Thuss-Patience PC, Hohenberger P, Benter T, Dörken B, Köhne CH. Weekly 24-hour infusion of high-dose 5-fluorouracil plus folinic acid in combination with mitomycin C for the treatment of advanced gastric cancer. Oncology. 2000 Jun;59(1):14-7.

Fu KL, Thuss PC, Fujino T, Digweed M, Liu JM, Walsh CE. Retroviral gene transfer for the assignment of Fanconi anemia (FA) patients to a FA complementation group. Human Genetics. 1998 Feb;102(2):166-9.

Lo ten Foe JR, Barel MT, Thuss P, Digweed M, Arwert F, Joenje H. Sequence variations in the Fanconi anaemia gene, FAC: pathogenicity of 1806insA and R548X and recognition of D195V as a polymorphic variant. Human Genetics. 1996 Nov;98(5):522-3.

Fallberichte

Thuss-Patience PC, Peters U, Jurkat-Rott K, Pink D, Kretzschmar A, Dörken B, Reichardt P. Acute hypokalemic tetraparesis induced by intravenous methotrexate. Journal of Clinical Oncology. 2003 May 1;21(9):1896-7

Thuss-Patience PC, Kretzschmar A, Krenn V, Dörken B, Reichardt P. Recurrent gastric adenocarcinoma with unusual metastatic localization and excellent response to docetaxel and 5-FU continuous infusion. Onkologie. 2003 Feb;26(1):63-5.

Thuss-Patience PC, Reichardt P. Recurrent gastric adenocarcinoma treated with docetaxel and continuous infusion 5-fluorouracil, Case Studies in Oncology, ISSN: 1528-7688, 2002, August, Vol 4, No.3

Pink D, Schoeler D, Lindner T, Thuss-Patience PC, Kretzschmar A, Knipp H, Vanhoefer U, Reichardt P. Severe hypoglycemia caused by paraneoplastic production of IGF-II in patients with advanced gastrointestinal stromal tumors: a report of two cases. Journal of Clinical Oncology. 2005 Sep 20;23(27):6809-11

Kretzschmar A, Pink D, Thuss-Patience P, Dörken B, Reichert P, Eckert R. Extravasations of oxaliplatin. Journal of Clinical Oncology . 2003 Nov 1;21(21):4068-9.

Köhne CH, Thuss-Patience P, Friedrich M, Daniel PT, Kretzschmar A, Benter T, Bauer B, Dietz R, Dörken B. Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity. British Journal of Cancer. 1998 Mar;77(6):973-7.

Übersichtsarbeiten

Thuss-Patience P, Biebl M, Stromberger M: Multimodale Therapie des Ösophaguskarzinoms; Der Onkologe, 2017; Onkologe .DOI 10.1007/s00761-017-0238-2

Baretton G, Dietel M, Gaiser T, Kirchner T, Kreipe HH, Quaas A, Röcken C, Rüschoff J, Tannapfel A, Lordick F, Al-Batran S, Hofheinz R, Lorenzen S, Moehler M, Thuss-Patience P. [HER2 testing in gastric cancer : Results of a meeting of German experts]. Pathologe. 2016

Mahlberg R, Lorenzen S, Thuss-Patience P, Heinemann V, Pfeiffer P, Möhler M. New Perspectives in the Treatment of Advanced Gastric Cancer: S-1 as a Novel Oral 5-FU Therapy in Combination with Cisplatin. Chemotherapy. 2017;62(1):62-70. Review.

Lordick F, Al-Batran SE, Dietel M, Gaiser T, Hofheinz RD, Kirchner T, Kreipe HH, Lorenzen S, Möhler M, Quaas A, Röcken C, Rüschoff J, Tannapfel A, Thuss-Patience P, Baretton G. HER2 testing in gastric cancer: results of a German expert meeting.J Cancer Res Clin Oncol. 2017 Mar 11. doi: 10.1007/s00432-017-2374-x. [Epub ahead of print] Review.

Lordick F, Al-Batran SE, Hofheinz RD, Lorenzen S, Thuss-Patience P, Baretton GB, Dietel M, Gaiser T, Kirchner T, Kreipe HH, Quaas A, Röcken C, Rüschoff J, Tannapfel A. [HER2 testing in gastric cancer - results of a German expert meeting]. Z Gastroenterol. 2016 Aug;54(8):791-6. doi: 10.1055/s-0042-110794. German.

Thuss-Patience P, Kutup A, Eble M. Adenokarzinome des Magens und gastroösophagealen Übergangs Neoadjuvante und adjuvante Therapie, Der Onkologe 2013/5:371-379 ,DOI 10.1007/s00761-012-2417-5

Henke O, Thuss-Patience PC. Hospiz- und Palliativversorgung von Patienten mit Migrationshintergrund in Deutschland. Zeitschrift für Palliativmedizin 2012; 13: 191-196

Breithaupt K, Thuss-Patience P. Metastatic gastric cancer: does second-line chemotherapy make sense?.Deutsche Medizinische Wochenschrift. 2010 Sep;135(38):1872-6. Epub 2010 Sep 14.

Thuss-Patience P C: ASCO Highlights 2009 – Magen- und Ösophaguskarzinom, Onkologie heute, 2009, 4, 34-37 Thuss-Patience P C: ASCO Highlights 2008 – Magen- und Ösophaguskarzinom, Onkologie heute, 2008, 5, 32-37

Thuss-Patience PC. ASCO update- Ösophagus und Magenkarzinom. Onkologie heute 2007; 4: 35-38 Thuss-Patience PC, Kretzschmar A, Reichardt P. Docetaxel in the treatment of gastric cancer. Future Oncology. 2006 Oct;2(5):603-20. Review.

Thuss-Patience PC, Reichardt P, Riess H, Kretzschmar A. [Recent progress in the treatment of colorectal cancer] Medizinische Klinik (Munich). 2006 Feb 15;101(2):114-9. Review. German.

Kretzschmar A, Thuss-Patience PC. Should integrated PET/CT be used for thoracic lesions. Controversies and Consensus in Imaging and Intervention 2004, issue 5

Reichardt P , Thuss-Patience PC. Adjuvante Chemotherapie des Magenkarzinoms. Journal Onkologie, ISSN 1618 7687, 2002, 03, 8-12 Thuss-Patience PC, Reichardt P. Chemotherapie des metastasierten Magenkarzinoms. Journal Onkologie, ISSN 1618 7687, 2002, 03, 13-17  

Buchbeiträge

P. Thuss-Patience: Palliative Chemotherapie: Standard und Individualisierung des Magen- und Kardiakarzinoms in Kreis ME, Seeliger H (Hrsg) Moderne Chirurgie des Magen- und Kardiakarzinoms. Springer Verlag GmbH Deutschland, 2017, DOI 10.1007/978-3-662-53188-4_8, Seiten 67-76

Peter Thuss-Patience, Benjamin Storek, Theo Daniel Kim, Oliver Henke und Bert Hildebrandt. Palliativmedizin und Betreuung sterbender Patienten in Harrisons Innere Medizin, Kapitel 10, Sonderausgabe der 19. Ausgabe von Harrison´s Principals of Internal Medicine ins Deutsche übersetzt. Herausgeber: M Dietel, N.Suttorp und M. Möckel, ABW Wissenschaftsverlag, 2016

Peter Thuss-Patience, Benjamin Storek, Oliver Henke und Bert Hildebrandt . Palliativmedizin und Betreuung sterbender Patienten in Harrisons Innere Medizin, Sonderausgabe der 18. Ausgabe von Harrison´s Principals of Internal Medicine ins Deutsche übersetzt. Herausgeber: M Dietel, N.Suttorp und M. Zeitz, ABW Wissenschaftsverlag, 2012

Peter Thuss-Patience, Bert Hildebrandt, Rike Born, Dagmar Schoeler, und Bernd Dörken: Palliativmedizin und Betreuung sterbender Patienten, Kapitel 11 (Seite 85-101) in Harrisons Innere Medizin, Sonderausgabe der 17. Ausgabe von Harrison´s Principals of Internal Medicine ind Deutsche übersetzt. Herausgeber: M Dietel, N.Suttorp und M. Zeitz, ABW Wissenschaftsverlag, 2008

Peter Thuss-Patience. Multimodale Therapie beim Magenkarzinom, in Peritonealkarzinose und maligner Ascites, Kiewe, Thiel (Hrsg). Uni-MED Verlag AG, Bremen, London, Boston, 2012, 2. Auflage, Seite 63-70

Heiko Neuß, Joachim Müller, Peter Thuss-Patience, Martin Stuschke. Ösophaguskarzinom In: Interdisziplinäre Entscheidungswege in der Onkologie, Schlag, Bamberg, Jäger (Hrsg). Deutscher Ärzte-Verlag, Köln, 2011. Seite 69-74

Peter Thuss-Patience. Epidemiologische Daten zum Magenkarzinom und aktuelle Therapiekonzepte. In: Biologie und zielgerichtete Therapie des Magenkarzinoms, Lordick (Hrsg). Uni-MED Verlag AG, Bremen, London, Boston, 2010, 1. Auflage, Seite 12-21